MWM
TEVA icon

Mosley Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Mosley Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$983 Buy
29
+9
+45% +$300 ﹤0.01% 569
2026
Q1 		$404 Buy
+20
New +$643 ﹤0.01% 442

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return

Mosley Wealth Management's TEVA Position: Q2 2026 in Review

Mosley Wealth Management increased its Teva Pharmaceuticals (TEVA) stake by 45% in Q2 2026, buying an estimated $300 and bringing the position to 29 shares worth $983. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Mosley Wealth Management first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 332 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Mosley Wealth Management held 29 shares of Teva Pharmaceuticals worth $983 as of Q2 2026.
  • Mosley Wealth Management bought 9 Teva Pharmaceuticals shares in Q2 2026, an estimated $300.
  • Teva Pharmaceuticals made up ﹤0.01% of Mosley Wealth Management's portfolio in Q2 2026, its #569 holding.
  • Mosley Wealth Management first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 332 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.